Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by pelabooston Feb 06, 2024 9:16am
222 Views
Post# 35864952

Idle Morning Thoughts

Idle Morning ThoughtsI am snowed in, and whilst I am buoying myself to go out and shovel the snow, I am going to try and figure out whether to hold, buy, or raise a little cash by selling a few of my shares. I confess a  bias towards holding or buying a few shares, given the current price. Then again this precipitous drop of late concerns me; once I knew Anson was on the scene I expected the price to fall but not this far.

By the way Q, the correct spelling is altar; I know you know that. These barrages of negative posts from numerous posters are confusing. These posters tell us they do not want us to lose money. I am not convinced. If they really want the best outcome for folks, it might be best to say nothing and let us make our own decisions. That is not going to happen, so I have to conclude they are not acting in the best interests of shareholders. The choice of Anson is problematic, but it does interest me that they are interested, and I am guessing that they feel they have a winner in the end. I may be wrong and they are happy with just the shorting. I did like de G, and if MC did make disparaging remarks about him MC has fallen even lower in my estimation.

Why am I still here. GOBLET. ONC/ONCY had little to do with GOBLET beyond supplying pelareorep.

Conclusion:

I am holding my current position. If we have some clarity by the end of the month, I shall add a few shares. Acknowledging of course that a company with little capital and possibly an ATM in their hands is not ideal.
<< Previous
Bullboard Posts
Next >>